Collegium Pharmaceutical Inc logo

COLL

Collegium Pharmaceutical Inc

$17.97

Earnings Summary

Revenue
$123.55Mn
Net Profits
$-5.19Mn
Net Profit Margins
-4.2%
PE Ratio
16.94

Highlights

Revenue:

Collegium Pharmaceutical Inc’s revenue jumped 48.96% since last year same period to $123.55Mn in the Q2 2022. On a quarterly growth basis, Collegium Pharmaceutical Inc has generated 47.52% jump in its revenue since last 3-months.

Net Profits:

Collegium Pharmaceutical Inc’s net profit fell -107.13% since last year same period to $-5.19Mn in the Q2 2022. On a quarterly growth basis, Collegium Pharmaceutical Inc has generated 60.28% jump in its net profits since last 3-months.

Net Profit Margins:

Collegium Pharmaceutical Inc’s net profit margin fell -104.78% since last year same period to -4.2% in the Q2 2022. On a quarterly growth basis, Collegium Pharmaceutical Inc has generated 73.07% jump in its net profit margins since last 3-months.

PE Ratio:

Collegium Pharmaceutical Inc’s price-to-earnings ratio after this Q2 2022 earnings stands at 16.94.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Collegium Pharmaceutical Inc post its latest quarter earnings

EPS Estimate Current Quarter
1.45
EPS Estimate Current Year
1.45

Highlights

EPS Estimate Current Quarter:

Collegium Pharmaceutical Inc’s earning per share (EPS) estimates for the current quarter stand at 1.45 - a 61.11% jump from last quarter’s estimates.

EPS Estimate Current Year:

Collegium Pharmaceutical Inc’s earning per share (EPS) estimates for the current year stand at 1.45.

Key Ratios

Key ratios of the Collegium Pharmaceutical Inc post its Q2 2022 earnings

Return on Assets (ROA)
0.01
Return on Equity (ROE)
-0.16
Dividend Per Share (DPS)
0

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Collegium Pharmaceutical Inc’s return on assets (ROA) stands at 0.01.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Collegium Pharmaceutical Inc’s return on equity (ROE) stands at -0.16.

Dividend Per Share (DPS):

Collegium Pharmaceutical Inc declared 0 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-10
0.9
0.44
-51.11%

Company Information

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium's headquarters are located in Stoughton, Massachusetts.

Organisation
Collegium Pharmaceutical Inc
Headquarters
Stoughton, Massachusetts, US
Employees
234
Industry
Health Technology
CEO
Joseph Ciaffoni